What temperature should be targeted in the first 24 hours after return of spontaneous circulation in a post‑cardiac arrest patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Cardiac Arrest Temperature Management

Maintain temperature control between 32-36°C for at least 36 hours in adult patients who remain unresponsive to verbal commands after return of spontaneous circulation (ROSC), with strict fever prevention (keeping temperature ≤37.5°C) for at least 72 hours total. 1

Target Temperature Range

The 2025 American Heart Association guidelines establish that temperature control should be maintained for a minimum of 36 hours post-ROSC 1. The acceptable target range is 32-36°C, based on evidence showing equivalent outcomes across this spectrum.

Key Evidence on Specific Temperatures

The landmark TTM trial (939 patients) demonstrated no difference in mortality or neurological outcomes between 33°C versus 36°C targets:

  • 6-month mortality: 50% at 33°C vs 48% at 36°C (HR 1.06,95% CI 0.89-1.28, p=0.51)
  • Poor neurological outcomes were identical at 52% in both groups 2

The ILCOR systematic review concluded that temperature control at 32-34°C does not improve survival or functional outcome compared to 35-36°C 3, supporting flexibility within the 32-36°C range.

Optimal Temperature Selection

Recent observational data from in-hospital cardiac arrest (36,514 patients, 2015-2024) reveals an inverted U-shaped relationship with survival:

  • Highest survival (72.7%) occurred at 36.8-37.3°C
  • Lowest survival at temperature extremes: <36.3°C (48.4%, aOR 0.42) and ≥38.8°C (51.5%, aOR 0.40) 4

One smaller prospective study (62 patients) found significantly increased hypotension at 32°C compared to 33-34°C (6.8-fold increased odds), without mortality benefit 5.

Practical Algorithm

  1. Initial target: Select 33-36°C based on institutional protocol

    • Consider 33-34°C if moderate hypoxic-ischemic brain injury predicted 3
    • Consider 36°C to minimize hypotension risk 5
  2. Duration: Maintain chosen temperature for minimum 36 hours 1

  3. Rewarming: Gradual at 0.5°C per hour after initial period

  4. Extended fever prevention: Keep temperature ≤37.5°C for 72 hours total 1, 3

Critical Pitfalls to Avoid

  • Do not cool below 32°C - increases adverse effects without benefit 5
  • Do not allow fever - temperatures ≥38.8°C associated with 60% increased mortality odds 4
  • Do not use rapid prehospital cooling with large-volume cold IV fluids - not recommended 6
  • Do not stop temperature control before 36 hours - insufficient duration 1

Applicability

These recommendations apply to:

  • Out-of-hospital cardiac arrest (shockable and non-shockable rhythms)
  • In-hospital cardiac arrest
  • Patients remaining comatose (not following commands) after ROSC 1, 6

The evidence base is strongest for out-of-hospital cardiac arrest with initial shockable rhythms, but guidelines extrapolate to all cardiac arrest etiologies 6.

Related Questions

What are the causes of cardiac arrest occurring immediately after percutaneous transluminal coronary angioplasty (PTCA)?
In a witnessed out‑of‑hospital cardiac arrest in an adult without contraindications, should emergency total extracorporeal life support (ECLS) be used instead of standard advanced cardiac life support (ACLS) with rescue extracorporeal membrane oxygenation (ECMO)?
In an 18‑year‑old male with a history of out‑of‑hospital cardiac arrest and a Medtronic implantable cardioverter‑defibrillator placed for secondary prevention who has never received ICD therapy, is it appropriate to have the device removed given his age and activity level?
When is it appropriate to list cardiac arrest as the immediate cause of death on a death certificate, and how should the underlying cause be recorded?
Is percutaneous coronary intervention (PCI) beneficial in a patient who suffered cardiac arrest and is currently comatose with a Glasgow Coma Scale of 3?
Should calcium gluconate be administered intravenously during hemodialysis for end-stage renal disease patients with hypocalcemia?
What is the utility of presepsin compared with neutrophil CD64 and other biomarkers for early recognition of sepsis in children?
What is the recommended ceftazidime dosage for an adult with chronic sinus discharge?
In a 32‑year‑old woman at 22 weeks gestation with suppressed TSH and elevated free T4 who stopped methimazole for two months (previous dose 20 mg daily), should methimazole be resumed?
What are the causes of hyperammonemia in a patient without cirrhosis?
What are the classifications of emicizumab?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.